课题基金 / 基金详情

Development of a Telehealth Screener and Assessment for Infants at-risk for ASD in Diverse Communities.

Development of a Telehealth Screener and Assessment for Infants at-risk for ASD in Diverse Communities.
为不同社区中有自闭症谱系障碍风险的婴儿开发远程医疗筛查和评估。
批准号:
10024067
负责人:
Meagan Ruth Talbott
金额:
$19.63万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-30 至 2022-08-31

项目摘要

项目成果

Meagan Ruth Talbott的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary The overall goal of this proposal is to develop a telehealth procedure for screening infants 6-12 months of age for early autism spectrum disorder (ASD) symptoms. While some promising biomarkers have been identified for infants in this age range, neurobiological methods are not feasible for widespread implementation, especially in rural and low-resource service systems. Families with early concerns are faced with long waitlists for an evaluation and often must travel long distances for evaluations at centers with appropriate expertise. Telehealth has been used as a cost-effective approach for increasing access to services across many disciplines, and there is some initial use of telehealth treatment approaches in ASD, but there are currently no established telehealth screening procedures to screen infants for ASD. Developing a telehealth screening protocol would provide families an opportunity to access highly trained clinicians and researchers with specialized expertise for initial screening before undertaking the cost and effort required to travel to a center. The first six months of funding will be used to develop, refine, and pilot test this parent-administered protocol in a sample of diverse infants 6-12 months (Aim 1). Feedback from parents and experts will inform final adaptations. The resulting protocol will subsequently be tested via telehealth in a pilot feasibility phase (Aim 2). 30 infants 6-12 months with early ASD symptoms and their caregivers will be recruited nationally, and will complete the telehealth screener quarterly for one year. We will examine the reliability of telehealth-derived measures of infant behavior across consecutive administrations, and compare these measures to existing parent-report measures to assess their validity. Acceptability to parents and feasibility of this telehealth approach to screening will also be evaluated. The overall goal of this project is to develop a protocol for systematically screening, assessing, and monitoring symptomatic infants from a distance. Doing so will increase families' access to specialized evaluations and decrease the significant waiting time between parents' first concerns and infants' first evaluation. It will also lay the groundwork for future efforts to conduct screening and intervention trials and will ultimately help to increase access to high-quality interventions and improve the developmental outcomes of many more underserved children with ASD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation of the TEDI: A Telehealth Evaluation of Development for Infants.
  • 批准号:
    10805226
  • 项目类别:
  • 资助金额:
    $3.06万
  • 财政年份:
    2023
  • 负责人:
    Meagan Ruth Talbott
  • 依托单位:
Leveraging Telehealth to Identify Infants at Elevated Likelihood for Autism in the First Year of life
  • 批准号:
    10712632
  • 项目类别:
  • 资助金额:
    $64.31万
  • 财政年份:
    2023
  • 负责人:
    Meagan Ruth Talbott
  • 依托单位:
Validation of the TEDI: A Telehealth Evaluation of Development for Infants.
  • 批准号:
    10373091
  • 项目类别:
  • 资助金额:
    $19.63万
  • 财政年份:
    2021
  • 负责人:
    Meagan Ruth Talbott
  • 依托单位:
Validation of the TEDI: A Telehealth Evaluation of Development for Infants.
  • 批准号:
    10196622
  • 项目类别:
  • 资助金额:
    $23.55万
  • 财政年份:
    2021
  • 负责人:
    Meagan Ruth Talbott
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: